Low-Density Lipoproteins in Atherogenesis

Lowering blood cholesterol to prevent heart disease. JAMA 1985, 253: 2080–2086.Google Scholar

Tyroler H: Lowering plasma cholesterol levels decreases risk of coronary heart disease: an overview of clinical trials. In Hypercholesterolemia and Atherosclerosis. Edited by Steinberg D, Olefsky JM. New York: Churchill Livingstone, 1987: 99–116.Google Scholar

Havel RJ: The role of liver in atherogenesis. Arteriosclerosis 1985, 2: 569–575.Google Scholar

Krauss RM: The tangled web of coronary risk factors. Am J Med 1990, 2 (suppl A): 36–41.Google Scholar

Krauss RM: Dense low density lipoproteins and coronary artery disease [review]. Am J Cardiol 1995, 75 (suppl B): 53–75.CrossRefGoogle Scholar

Veniant MM, Pierotti V, Newland D, et al.: Susceptibility to athero-sclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J Clin Invest 1997, 100: 180–188.PubMedCrossRefGoogle Scholar

Pittman RC, Carew TE, Attie AD, et al.: Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal and in receptor-deficient mutant rabbits. J Biol Chem 1982, 257: 7994–8000.PubMedGoogle Scholar

Brown MS, Goldstein JL: A receptor-mediated pathway for choles-terol homeostasis. Science 1986, 232: 34 47.Google Scholar

Wang X, Briggs MR, Hua X, et al.: Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 1993, 268: 14497–14504.PubMedGoogle Scholar

Yang J, Sato R, Goldstein JL, et al.: Sterol-resistant transcription in Cho 61b caused by gene rearrangement that truncates SREBP-2. Genes Dev 1994, 8: 1910–1919.PubMedCrossRefGoogle Scholar

Ishibashi S, Brown MS, Goldstein JL, et al.: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92: 883–893.PubMedCrossRefGoogle Scholar

Scanu AM: Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role. Mol Cell Biochem 1992, 113: 127–131.PubMedCrossRefGoogle Scholar

Scanu AM, Fless GM: Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest 1990, 85: 1709–1715.PubMedCrossRefGoogle Scholar

Gugliucci Creriche A, Stahl AJ: Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge. Scand J Clin Lab Invest 1993, 53: 125–132.CrossRefGoogle Scholar

Steinberg D, Parthasarathy S, Carew TE, et al.: Beyond cholesterol. Modifications of low-density lipoprotein that increase its athero-genicity. N Engl J Med 1989, 320: 915–924.PubMedCrossRefGoogle Scholar

Parthasarathy S: Modified Lipoproteins in the Pathogenesis of Atherosclerosis. Austin, TX: RG Landes Publishers, CRC Press Inc; 1994.Google Scholar

Steinbrecher UP: Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987, 262: 3603–3608.PubMedGoogle Scholar

Gerrity RG: The role of the monocyte in atherogenesis. Am J Pathol 1981, 103: 181–190.PubMedGoogle Scholar

Goldstein JL, Ho YK, Basu SK, et al.: Binding site on macrophages that mediates uptake and degradation of cetylated low density lipoproteins, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979, 76: 333–337.PubMedCrossRefGoogle Scholar

Haberland ME, Fogelman AM, Edwards PA: Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA 1982, 79: 1712–1716.PubMedCrossRefGoogle Scholar

Brown MS, Goldstein JL: Atherosclerosis. Scavenging for receptors [news]. Nature 1990, 343: 508–509.PubMedCrossRefGoogle Scholar

Kodama T, Freeman M, Rohrer L, et al.: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990, 343: 531–535.PubMedCrossRefGoogle Scholar

Takahashi K, Naito M, Kodama T, et al.: Expression of macrophage scavenger receptors in various human tissues and atherosclerotic lesions. Clin Biochem 1992, 25: 365–368.PubMedCrossRefGoogle Scholar

Yla Herttuala S, Rosenfeld MR, Parthasarathy S, et al.: Gene expres-sion in macrophage-rich human atherosclerotic lesions. 15-lipoxy-genase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991, 87: 1146–1152.CrossRefGoogle Scholar

Sakaguchi H, Takeya M, Suzuki H, et al.: Role of macrophage scav-enger receptor in diet-induced atherosclerosis in mice. Lab Invest 1998, 78: 423–434.PubMedGoogle Scholar

Parthasarathy S, Steinberg D, Witztum JL: The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 1992, 43: 219–225.PubMedCrossRefGoogle Scholar

Cushing SD, Berliner JA, Valente AJ, et al.: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990, 87: 5134–5138.PubMedCrossRefGoogle Scholar

Ku G, Thomas CE, Akeson AL, et al.: Induction of interleukin 1 ß expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem 1992, 267: 14183–14188.PubMedGoogle Scholar

Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progres-sion of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987, 84: 7725–7729.PubMedCrossRefGoogle Scholar

Sparrow Cl’, Doebber TW, Olszewski J, et al.: Low density lipopro-tein is protected from oxidation and the progression of atheroscle-rosis is slowed in cholesterol-fed rabbits by the antioxidant N,N’-diphenyl-phenylenediamine. J Clin Invest 1992, 89: 1885–1891.CrossRefGoogle Scholar

Verlangieri AJ, Bush MJ: Effects of d-alpha-tocopherol supplemen-tation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992, 11: 131–138.PubMedGoogle Scholar

Kita T, Nagano Y, Yokode M, et al.: Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Am J Cardiol 1988, 62 (suppl B): 13–19.CrossRefGoogle Scholar

Gaziano JM, Manson JE, Buring JE, et al.: Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 1992, 669: 249–258.PubMedCrossRefGoogle Scholar

Gey KF, Puska P: Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemi-ology. Ann NY Acad Sci 1989, 570: 268–282.Google Scholar

Stephens NG, Parsons A, Schofield PM, et al.: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347 (suppl A): 781–786.Google Scholar

Shern-Brewer R, Santanam N, Wetzstein C, et al.: Exercise and cardiovascular disease: a new perspective. Arteriosclerosis Thromb Vasc Biol 1998, 18: 1181–1187.CrossRefGoogle Scholar

Santanam N, Shern-Brewer R, McClatchey R, et al.: Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Research 1998, 39: 2111–2118.Google Scholar

Ramasamy S, Parthasarathy S, Harrison DG: Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J Lipid Res 1998, 39; 268–276.PubMedGoogle Scholar

Palinski WS, Miller E, Wiztum JL: Immunization of LDL receptor deficient rabbits with homologous malondialdehyde-modified reduces atherogenesis. Proc Natl Acad Sci USA 1995, 92: 821–825.PubMedCrossRefGoogle Scholar

Yang C, Gu Z, Weng S, et al.: Structure of apolipoprotein B-100 of human low density proteins. Arteriosclerosis 1989, 9: 96–108.PubMedCrossRefGoogle Scholar

Briggs MR, Yokoyama C, Wang X, et al.: Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 1993, 268: 14490–14496.PubMedGoogle Scholar

Goldstein JL, Brown MS, Anderson RG, et al.: Receptor-mediated endocytosis: concepts emerging from the LDL receptor system [review]. Annu Rev Cell Biol 1985, 1: 1–39.PubMedCrossRefGoogle Scholar

Grundy SM: Cholesterol and Atherosclerosis: Diagnosis and Treatment. Philadelphia: JB Lippincott; 1990.Google Scholar

Austin MA, Hokanson JE: Epidemiology of triglycerides, small dense low-density lipoprotein, and lipoprotein(a) as risk factors for coronary heart disease [review]. Med Clin North Am 1994, 78: 99–115.PubMedGoogle Scholar

Callow MJ, Stoltzfus LJ, Lawn RM, et al.: Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci USA 1994, 91: 2130–2134.PubMedCrossRefGoogle Scholar

Rosenfeld ME, Khoo JC, Miller E, et al.: Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. I Clin Invest 1991, 87: 90–99.CrossRefGoogle Scholar

Parthasarathy S, Santanam S, Auge N: Antioxidants and Low density Lipoprotein Oxidation. In Antioxidant Status, Diet, Nutrition, and Health. Edited by Papas A. Boca Raton, FL: CRC Press; 1999: 347–369.Google Scholar

Santanam N, Parthasarathy S: Paradoxical actions of antioxidants in the oxidation of low-density lipoprotein by peroxidases. J Clin Invest 1995, 95: 2594–2600.PubMedCrossRefGoogle Scholar

Esterbauer H, Striegl G, Puhl H, et al.: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989, 6: 67–75.PubMedCrossRefGoogle Scholar

Steinberg D: Metabolism of lipoproteins and their role in atheroge-nesis. Atheroscler Rev 1988, 18: 1–23.Google Scholar

Quinn MT, Parthasarathy S, Steinberg D, et al.: Oxidatively modi-fied low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987, 84: 2995–2998.PubMedCrossRefGoogle Scholar

Parthasarathy S, Rankin SM: Role of oxidized low density lipopro-tein in atherogenesis. Prog Lipid Res 1992, 31: 127–143.PubMedCrossRefGoogle Scholar

Palinski W, Rosenfeld ME, Yla Herttuala S, et al.: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989, 86: 1372–1376.PubMedCrossRefGoogle Scholar

Rohrer L, Freeman M, Kodama T, et al.: Coiled-coil fibrous domains mediate ligand binding by scavenger receptor type II. Nature 1990, 343: 570–572.PubMedCrossRefGoogle Scholar

Fogelman AM, Haberland ME, Seager J, et al.: Factors regulating the activities of the low density lipoprotein receptor and the scav-enger receptor on human monocyte-macrophages. J Lipid Res 1981, 22: 1131–1141.PubMedGoogle Scholar